Tousignant Jennifer bought VRDN
August 19, 2026 · Form 4 insider transaction
Tousignant Jennifer bought 10,000 shares of Viridian Therapeutics, Inc. at $14.41 per share, a transaction worth $144.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$14.41
Total value
$144.1K
InsiderTousignant Jennifer
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 19, 2026
Filing dateAugust 20, 2026
Shares owned after10,000
OwnershipDirect
10b5-1 planNo
AmendedNo